Return of induction chemotherapy in head and neck squamous cell cancers: is this time different?

Lancet Oncol. 2016 Nov;17(11):1465-1467. doi: 10.1016/S1470-2045(16)30444-2. Epub 2016 Sep 27.

Author

Michael T Spiotto¹

Affiliation

¹ Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, IL 60637, USA; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA. Electronic address: mspiotto@radonc.uchicago.edu.

PMID: 27686944
DOI: 10.1016/S1470-2045(16)30444-2

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cisplatin
Epithelial Cells
Head and Neck Neoplasms*
Humans
Induction Chemotherapy*

Substances

Cisplatin